Atlas Trials

Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024% in Japanese Subjects With OAG or OHT

Clinical trial NCT01895972 · COMPLETED

Trial details

NCT number
NCT01895972
Sponsor
Bausch & Lomb Incorporated
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
GlaucomaOcular Hypertension
Start date
2013-07-05
Primary completion
2015-04-02
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.